Signum Surgical is a company who develops implant to encourage healing in a colorectal condition.
Founded in 2014 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is a medtech platform striving to develop technology that could cure perianal fistula. Bambury and Zilversmit, who met on the BioInnovate Ireland programme at NUI Galway, recognised a lack of innovation surrounding the treatment of perianal fistulas (small tunnels that develop between the end of the bowel and the skin near the anus). The device developed by Signum Surgical is implanted post-surgery to prevent reinfection and to allow a faster healing process.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 20, 2022 | Series Unknown | €2.90M | 1 | HBAN Medtech Syndicate | — | Detail |
Oct 23, 2016 | Series A | €2.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
HBAN Medtech Syndicate | Yes | Series Unknown |
Glanzmann Enterprises | — | Series A |